An Important Step Towards Better Diagnosis and Treatment
The European Union has awarded €7.5 million to DISCOVER-ME, a large international research consortium dedicated to ME/CFS. This funding marks an important milestone for ME/CFS research across Europe.
DISCOVER-ME brings together more than twenty universities, research institutes, biobanks, companies, and patient organisations from Europe and Canada, including the Dutch ME/CFS Cohort and Biobank (NMCB). By combining expertise, data, and biological samples, the consortium will be able to conduct larger-scale and more targeted research into ME/CFS.
As part of DISCOVER-ME, 2,000 participants, including people with ME/CFS and healthy controls, will complete an extensive questionnaire. Researchers will use this information to investigate whether different clinical subgroups can be identified within ME/CFS. In addition, biological samples from up to 900 participants from five European biobanks—including samples from the NMCB biobank—will undergo in-depth analysis.
The researchers will study several biological systems and processes that may play a role in ME/CFS, including the immune system, energy metabolism, the nervous system, blood vessels, and gene expression.
One of the project’s main objectives is to identify biomarkers—measurable biological characteristics that may help improve the diagnosis of ME/CFS. The consortium will also investigate whether different patient subgroups exist, each characterised by distinct underlying biological mechanisms.
A better understanding of these differences could help clinicians diagnose ME/CFS more quickly and pave the way for more targeted treatments. For example, it may show that different groups of patients benefit from different therapeutic approaches.
For NMCB, participation in DISCOVER-ME means that Dutch researchers are contributing to one of the largest international biomedical research programmes on ME/CFS to date. By combining data and biological samples from multiple countries, researchers can identify patterns that often remain undetected in smaller studies.
What Does This Mean for People with ME/CFS?
By bringing together expertise, data, and biological materials from researchers across different countries, DISCOVER-ME is expected to accelerate scientific understanding of ME/CFS.
The funding also represents an important signal of recognition. Through this investment, the European Union acknowledges the need for large-scale biomedical research into ME/CFS. Its support for this international collaboration reflects the growing recognition of ME/CFS as a serious medical condition that requires sustained scientific attention.
Although the project will not immediately result in a new diagnostic test or treatment, it is expected to provide the scientific foundation for improved diagnostics, better-designed clinical studies, and ultimately more effective and personalised treatments.
Read more about the research project here